<?xml version="1.0" encoding="UTF-8"?>
<p>It should also be scalable, economical, and compliant with the FDAâ€™s cGMP regulations. The most common practice for NoV VLP purification is density gradient ultracentrifugation [
 <xref ref-type="bibr" rid="CR0008106">106</xref>, 
 <xref ref-type="bibr" rid="CR0008108">108</xref>, 
 <xref ref-type="bibr" rid="CR0008133">133</xref>, 
 <xref ref-type="bibr" rid="CR0008144">144</xref>]. While these methods are useful for characterizing VLP size and assembly [
 <xref ref-type="bibr" rid="CR0008107">107</xref>, 
 <xref ref-type="bibr" rid="CR0008133">133</xref>, 
 <xref ref-type="bibr" rid="CR0008144">144</xref>], they are not practical for commercial VLP manufacturing as they are difficult to scale-up and time-consuming [
 <xref ref-type="bibr" rid="CR0008143">143</xref>, 
 <xref ref-type="bibr" rid="CR0008145">145</xref>]. They may also be problematic for preserving the integrity of VLPs because the hyperosmotic gradient agents and severe centrifugation force can often shear VLPs [
 <xref ref-type="bibr" rid="CR0008146">146</xref>]. To meet the demand for more scalable and robust methods of NoV VLP processing, a new trend has started toward more sophisticated methods like filtration and chromatography [
 <xref ref-type="bibr" rid="CR000831">31</xref>]. For example, our group has recently developed a robust and scalable downstream processing scheme for recovering NVCP VLPs from plants (Fig. 
 <xref rid="Fig00085" ref-type="fig">8.5</xref>). 
</p>
